Intriguingly, studies in a Blk knockout mouse demonstrated that B cell development and the humoral immune response are not substantially impacted by BLK depletion, suggesting BLK-specific inhibitors may have few on-target off-tumor effects (Texido et al., 2000). Here, BLK is linked to neoplasm.